V65F (p.Val65Phe) variant of SATB2 (DNA-binding protein SATB2)
V65F (p.Val65Phe) in SATB2 (DNA-binding protein SATB2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.95 / 1. The record also includes structural context.
V65F (p.Val65Phe) variant details
- p.Val65Phe
- cosmic curated COSV10502
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.945
- ESM-1b 1.00
- AlphaMissense 0.88
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available